Searched for
KIRAN MAZUMDAR SHAW
Indian pharma's risk aversion holding back innovation: Kiran Mazumdar-ShawBiocon chairperson Kiran Mazumdar-Shaw calls for greater use of digital technology to speed up drug development, as industry leaders push f...- Existential threats join bubble fears as AI mood sobers at Singapore forumsDuring conferences in Singapore, significant apprehensions regarding the dangers of artificial intelligence emerged among investors and pol...
- Indian companies must invest in R&D, move from generics to innovation-led industry: Pharma leadersIndian pharmaceutical leaders emphasize the need for investment in innovation to transition from generics to innovative products. They high...
- Bengaluru CEO spends Rs 2700 to fix broken footpath himself. IIT Madras alumnus says repeated complaints went unansweredBengaluru CEO and IIT Madras alumnus Siddharth Dialani took matters into his own hands to address a hazardous footpath that posed a risk to...
- Kiran Mazumdar-Shaw has a career lesson from 3 Nobel prize winners as AI forces layoffs and changes jobs across the worldBiocon chairperson Kiran Mazumdar-Shaw shared a message on persistence from three 2023 Nobel Prize winners as AI reshapes jobs and companie...
- Rs 8.3 lakh Fendi bag resembling 'Rs 500' Indian market designs: Why the luxury brand did not 'credit' Indian artisans, ask Harsh Goenka, Kiran Mazumdar-ShawFendi’s Rs 8.3 lakh multicolour bag, featuring 39,500 beads and 475 mirrors, has sparked an online debate over its resemblance to tradition...
- ET Under 40 2026: How technology is creating younger leadersThe rise of technology is paving the way for younger Indians to step into leadership roles much earlier. Kiran Mazumdar-Shaw predicts that ...
- ET 40 Under Forty: Meet the trailblazers of India’s tomorrowThe Economic Times 40 Under Forty awards honored young leaders shaping India's future. The event celebrated personal and professional achie...
- Biocon shares rise 3% after Rs 638-crore block deal; Active Pine likely sellerBiocon shares rose after a block deal involving around 1.65 crore shares. Investor Active Pine was reportedly looking to sell up to 1.66 cr...
- Biocon shares: Active Pine may divest up to 1% equity worth Rs 638 crore via block dealActive Pine is likely to sell up to 1.66 crore Biocon shares, worth Rs 638 crore, through a block deal at Rs 385 per share. The development...
- No plastic, only coconut leaves: Bengaluru Christ University professor builds Rs 70 crore business by making eco-friendly straws, products are exported to 25 countriesFollowing a chance discovery, an English professor at Christ University in Bengaluru has pioneered eco-friendly, plastic-free straws made f...
- Karnataka seeks deeper US partnerships in innovation, skilling as Shivakumar unveils Quantum City planSpeaking at the inauguration of the QUANTUM exhibition at Science Gallery Bengaluru in the presence of US Ambassador Sergio Gor, Shivakumar...
- “Not Australia, but India rejected me for being a woman”: Kiran Mazumdar-Shaw clarifies how gender bias led her to build Biocon in viral postBiocon founder Kiran Mazumdar-Shaw intervened and clarified after a viral post claimed that Australia denied her a master brewer role due t...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- Bengaluru’s civic workers get surprise gift from Biocon’s Kiran Mazumdar-ShawBiocon founder Kiran Mazumdar-Shaw had decided to send sweet boxes to each one of them as a festival gift. “We take them (poura karmikas) f...
- Hep C drugs will be a Rs 1,000-cr market; Cimivir-L will boost Biocon's virology biz: Kiran Mazumdar-Shaw"The market for Hepatitis C drugs is fairly large. There are high incidences of Hepatitis C in many parts of our country."
- We need to augment focus on Asian partners: Kiran Mazumdar Shaw, Biocon"New govt is saying that they certainly want to have the West as strong partners, but we need to improve and augment our focus on our Asian...
- Kiran Mazumdar-Shaw succeeds Mukesh Ambani as Chairperson of IIM-B boardWith this, Kiran Mazumdar-Shaw becomes the first woman chairperson of any IIM board in the country.
- Looking for global partner for psoriasis drug: Kiran Mazumdar Shaw, BioconThe plan is that the India drug will launched as an intravenous infusion and it has been indicated for psoriasis, says Kiran Mazumdar Shaw.
- Biocon is at a strong price disadvantage to global players : Kiran Mazumdar ShawThe National Pharmaceutical Pricing Authority has allowed pharma cos to increase the price of insulin drugs. Kiran Mazumdar Shaw, Chairpers...
Load More
